Skip to main content

Eloxx Pharmaceuticals Inc. Common Stock (ELOX)

About The Company

ELOX Stock Market Logo

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company’s lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis.

IPO Year Sector Industry
N/A Health Care Biotechnology: Pharmaceutical Preparations

Eloxx Pharmaceuticals Inc. (ELOX) Latest News

Company Contact & Address (ELOX)

Corporate Headquarters Phone Website
480 ARSENAL WAY,
WATERTOWN,
Massachusetts,
2472,
United States
+1 781 577-5300 Official ELOX Website

ELOX Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ELOX

Jobs & Employment at Eloxx Pharmaceuticals Inc.

LinkedIn Company Page https://www.linkedin.com/company/eloxx-pharmaceuticals
Official Career & Employment Page Careers, Jobs & Employment at Eloxx Pharmaceuticals Inc. (ELOX)

Related & Similar Stock Symbols

BMRC Stock Market Price & News

BMRC

Bank of Marin Bancorp Common Stock

HOFV Stock Market Price & News

HOFV

Hall of Fame Resort & Entertainment Company Common …

GJO Stock Market Price & News

GJO

Synthetic Fixed-Income Securities Inc. Synthetic Fixed-Income Securities …